About The Position

The Senior, Director, Health Policy & Reimbursement shapes the policy, coding, and reimbursement environment needed to accelerate rapid whole-genome sequencing (rWGS) adoption, support product innovation, enable strategic growth, and expand patient access to Baylor Genetics testing. The role leads federal and state health policy strategy and external representation, monitors legislative, regulatory, coding, payment, and coverage developments, and translates changes into enterprise implications and action plans. The position leads coding strategy for new and existing products, including CPT applications and coordination of ICD-10-CM proposals. It develops evidence, clinical-workflow, utilization, and economic rationales for coding, valuation, coverage, and reimbursement submissions. It also leads state strategies to advance adoption and sustainable funding of rWGS for critically ill infants and children, and partners with authorized Government Affairs resources, coalitions, and registered lobbyists on compliant engagement with policymakers. The role integrates reimbursement and policy diligence into product pipeline planning and business-development evaluations, guides responses to proposed rules and payer policies, and works with Revenue Cycle and Finance to assess payment adequacy, coding performance, denials, fee-schedule changes, and financial impact. It prepares policy briefs, scenario analyses, risk assessments, and recommendations for senior leadership and the Board, while maintaining governance, documentation, and compliance controls for policy engagement and external representation. People leadership responsibilities include leading, coaching, developing, and retaining a team; setting objectives and accountability; conducting portfolio, policy, and pipeline reviews; developing succession plans; and promoting integrity, evidence-based advocacy, cross-functional partnership, and execution excellence. The position is remote and requires approximately 40–50% domestic travel.

Requirements

  • Bachelor’s degree in Health Policy, Public Health, Life Sciences, Business, Healthcare Administration, Health Economics, or a related field.
  • 7 or more years of experience leading teams in health policy and reimbursement.
  • 12 or more years of progressive experience, including the stated experience in health policy, reimbursement, coding, government affairs, market access, or related healthcare leadership roles and direct laboratory health policy and reimbursement experience.
  • At least 8 years of progressive experience in health policy, reimbursement, coding, government affairs, market access, or related healthcare leadership roles.
  • At least 8 years of direct laboratory health policy and reimbursement experience; molecular diagnostics, genomics, or precision medicine experience is preferred.
  • Demonstrated experience leading CPT coding strategy and familiarity with ICD-10-CM coordination and federal coding processes.
  • Demonstrated success influencing state or federal health policy, reimbursement, Medicaid, or legislative initiatives through compliant advocacy and coalition engagement.
  • Experience leading and developing teams responsible for policy, coding, reimbursement, or government affairs.
  • Ability to interpret legislation, regulations, coding guidance, payment policy, and payer requirements and translate them into business strategy.
  • Executive-level communication, deductive storytelling, negotiation, and cross-functional influence skills.
  • Ability and willingness to travel approximately 40–50% domestically.

Nice To Haves

  • MBA, MPH, MHA, JD, MS, PharmD, PhD, or equivalent advanced degree.
  • Experience with rWGS, WGS, WES, NGS, rare disease, oncology genomics, reproductive genetics, or pediatric critical care.
  • Experience with AMA CPT processes, CMS payment systems, state Medicaid programs, and CDC ICD-10-CM coordination processes.
  • Established relationships with laboratory trade associations, patient-advocacy organizations, state policy coalitions, federal agencies, and legislative stakeholders.
  • Experience supporting product pipeline strategy, licensing, mergers and acquisitions, or post-acquisition integration.
  • Experience developing public-comment letters, legislative language, fiscal-impact analyses, or reimbursement evidence packages.

Responsibilities

  • Monitor federal and state legislative, regulatory, coding, payment, and coverage developments affecting clinical laboratories, molecular diagnostics, genomics, rare disease, and precision medicine; translate developments into enterprise implications and action plans.
  • Represent Baylor Genetics in health policy matters with trade associations, standards-setting organizations, public agencies, coalitions, payer policy forums, and other external stakeholders.
  • Lead coding strategy for new and existing products, including CPT applications through the American Medical Association and coordination of ICD-10-CM proposals through the Centers for Disease Control and Prevention and other federal processes.
  • Develop evidence, utilization, clinical-workflow, and economic rationales for coding, valuation, coverage, and reimbursement submissions.
  • Lead state health policy strategies to advance adoption and sustainable funding of rapid WGS for critically ill infants and children, including Medicaid, appropriations, coverage mandates, pilots, and implementation pathways.
  • Partner with authorized Government Affairs resources, external coalitions, and registered lobbyists to engage state legislatures and members of Congress in accordance with Legal and Compliance requirements.
  • Lead upstream reimbursement planning for new products, platform extensions, and tuck-in acquisitions, including coding, coverage, payment, evidence, channel, operational, and commercialization-readiness assessments.
  • Integrate reimbursement and policy diligence into business-development evaluations and identify access risks, evidence gaps, investment requirements, and post-close integration priorities.
  • Guide responses to proposed federal and state rules, payer policies, fee schedules, laboratory payment reforms, and other public-comment opportunities.
  • Prepare executive-ready policy briefs, scenario analyses, risk assessments, and recommendations for senior leadership and the Board, as appropriate.
  • Partner with Revenue Cycle and Finance to assess payment adequacy, coding performance, denial patterns, fee-schedule changes, and financial impact.
  • Maintain governance, documentation, and compliance controls for policy engagement, coding submissions, coalition activity, and external representation.
  • Lead, coach, develop, and retain a team responsible for health policy, coding, reimbursement strategy, and government-affairs coordination.
  • Establish measurable objectives, operating rhythms, decision rights, and accountability aligned to enterprise priorities.
  • Conduct portfolio, policy, and pipeline reviews; remove barriers and ensure timely execution of critical submissions and advocacy initiatives.
  • Develop succession plans and expand organizational capability in laboratory policy, coding, payment, and state-government engagement.
  • Promote integrity, evidence-based advocacy, cross-functional partnership, and execution excellence.
  • Deliver an annual federal and state health policy strategy with prioritized issues, stakeholders, risks, and action plans.
  • Develop CPT and ICD-10-CM coding roadmaps, applications, evidence packages, and milestone plans for priority products.
  • Develop a state rWGS adoption strategy, including legislative, Medicaid, appropriations, coalition, and implementation pathways.
  • Execute congressional and state policy engagement plans with authorized Government Affairs and Compliance partners.
  • Prepare pipeline and acquisition reimbursement-readiness assessments with go/no-go considerations and investment requirements.
  • Provide executive dashboards covering policy developments, coding milestones, reimbursement risks, advocacy progress, and expected business impact.
  • Advance coding milestones and favorable outcomes for priority CPT and ICD-10-CM initiatives; support rWGS policies, Medicaid pathways, appropriations, and programs; and mitigate material policy and reimbursement risks.
  • Support improvement in payment adequacy, coding clarity, reimbursement predictability, and access for Baylor Genetics products, as well as team performance and delivery of annual objectives.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service